(Source: Emory University) A pilot study has found that a combination of drugs used to treat the hepatitis C virus could substantially reduce the time of treatment to as little as three weeks for some patients. Although the treatment did not work that quickly for all patients, doctors could see whether the three drug regimens selected were going to be successful by just the second day. The study from Hong Kong, called SODAPI, will be presented at the AASLD 'Liver Meeting' in San Francisco. According to the research team, it could lead to substantially reduced time of treatment for hepatitis C virus infection, improved drug...
↧